Lisa Morris, M.D.

Professional Background

Dr. Lisa Morris is a board-certified and fellowship-trained Mohs Surgeon and Assistant Professor of Dermatology at the University of Kansas Health System.

Originally from Lee’s Summit, Missouri, Dr. Morris earned her bachelor’s degree in Biological Engineering from the University of Missouri. She received her medical degree from the University of Missouri–Columbia School of Medicine in 2020, where she was elected to both Alpha Omega Alpha (AOA) and the Gold Humanism Honor Society (GHHS). She completed her internship at the Spokane Teaching Health Center before completing her dermatology residency at the Washington University School of Medicine in St. Louis, Missouri where she served as Chief Resident. She completed her fellowship in Micrographic Surgery and Dermatologic Oncology at the University of Vermont Medical Center in 2025.

Dr. Morris finds great reward in forming personal connections with patients and strives to ensure that each individual feels valued, understood, and confident in their care. She specializes in Mohs surgery for skin cancers and performs specialized immunohistochemical staining for melanoma and squamous cell carcinoma. In addition, she performs a wide range of dermatologic procedures for both benign and malignant lesions, including excisions, destructions, and intralesional chemotherapies.

• BS, Biological Engineering, University of Missouri - Columbia
• MD, Medicine, University of Missouri - Columbia
• Internship, Transitional Year, Spokane Teaching Health Center
• Residency, Dermatology, Washington University in St. Louis School of Medicine
• Clinical Fellowship, Micrographic Surgery and Dermatologic Oncology, University of Vermont

Research

Overview

Dr. Morris has authored multiple peer-reviewed publications. She studied cutaneous T-cell lymphoma at MD Anderson Cancer Center, contributing to several publications on Sézary syndrome and related conditions. Her more recent work focuses on surgical safety and innovation in dermatologic surgery, including the use of tranexamic acid in Mohs micrographic surgery, reconstructive techniques, and public health initiatives.